RecallDepth
Class II Ongoing

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

This recall is currently active, issued August 6, 2025. It was issued by Hikma Pharmaceuticals Usa Inc..

Company
Hikma Pharmaceuticals Usa Inc.
Recall Initiated
July 22, 2025
Posted
August 6, 2025
Recall Number
D-0551-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
382,775 1mL vials
Firm Location
Cherry Hill, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot # K24118, exp. date 10/31/2026

More recalls by Hikma Pharmaceuticals Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls